Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 19 results found. Search for [ Controller General of Patents ]

Results 1 to 19 of 19
Goutam Das
March 3, 2020
Exponential technologies are changing how and where we learn


Joe C Mathew
February 22, 2020
Ever since India changed its intellectual property laws in 2005 to permit product patents in India, the country has been increasingly granting patents


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


Joe C Mathew
November 22, 2019
The Union Cabinet on Wednesday approved the proposal for adoption of Patent Prosecution Highway (PPH) programme by the Indian Patent Office (IPO) with patent offices of various other interest countries or regions


PTI
February 7, 2019



PTI
November 24, 2018



PTI
February 2, 2018



PB Jayakumar
Delhi, April 1, 2017
India moved to the product patent regime - which allowed patents for innovations for a period of 20 years in tune with international norms - in 2005.


By E. Kumar Sharma
Delhi, July 23, 2016
Indian drug makers are slugging it out with Big Pharma over launch of biosimilars. Will they be able to hold their fort in this emerging space?


PTI
New Delhi, November 17, 2015
The Swiss drug major said that a highly predictable IPR regime is needed for the Indian pharma industry to develop to the level of the US or Europe.


P.B. Jayakumar
March 5, 2015
The US is mounting pressure on India to agree to its terms in pharma IP protection. How long can India resist?


Arpita Mukherjee
Delhi, March 29, 2014
However, despite the sustained growth, the founders say the company could have expanded much faster had they taken more people on board and \"delegated work\" much earlier.


E. Kumar Sharma
February 7, 2014
Roche has sought an injunction against two pharma companies - the Bangalore based Biocon and US-based Mylan. The two companies have launched a co-developed biosimilar of the drug Herceptin, which treats certain types of breast cancers. Formerly, Roche held the patent for Herceptin, but unexpectedly gave it up last year.


E. Kumar Sharma
December 7, 2013
There are more than a dozen drugs in important cancer treatment areas that are not available in India. The new drug flow into India has slowed down significantly and it is a matter of concern for oncologists and cancer patients.


BT Online Bureau
March 7, 2013
Bayer AG  will approach the high court in Mumbai against a ruling by Intellectual Property Appellate Board that upheld the compulsory licence issued to India's Natco Pharma to make and sell a low-cost generic of the German drug major's patented cancer drug Nexavar.


Taslima Khan
November 23, 2012
Despite many difficulties, a number of other entrepreneurs are setting up their own ventures to make novel, low-cost medical equipment suited for Indian conditions.


PTI
Berlin, May 10, 2012
Bayer holds the patent for Nexavar till 2020 and it will \"vigorously defend its patent within the available legal framework\".


Chaitanya Kalbag
March 28, 2012
Caprice and cowardice were both on display last fortnight. Ten days after a bunch of state election results delivered a hard punch in the Congress party's solar plexus, Pranab Mukherjee delivered a Budget for 2012/13 that was simultaneously retrograde and revanchist.


Shamni Pande
March 5, 2009
In businesses, big or small, ranging from manufacturing to music, the fight for intellectual property is getting intense. Neglect it and you could be out of business.


PAGES 1 OF 1